Oneness Biotech Co Ltd develops botanical new drugs and several biological-active new chemical entities that are purified and molecularly modified from these botanical sources.

Oneness Announces The Information About The Investor'S
Conference Of 2024 Q4.

(Supplementary Explanation) Announcement Of The
Company'S Board Of Directors' Resolution On The Change
Of The Cash Capital Increase Plan For 2020

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Oneness Biotech (4743 TT)

Oneness Announces The Information About The Investor'S Conference Of 2024 Q4.

(Supplementary Explanation) Announcement Of The Company'S Board Of Directors' Resolution On The Change Of The Cash Capital Increase Plan For 2020

Announcement Of The Company'S Board Of Directors' Resolution On The Change Of The Cash Capital Increase Plan For 2020

The Company'S 2024q3 Consolidated Financial Statements Have Been Approved By The Board Of Directors

Bonvadis Topical Cream Received Medical Device Marketing Authorization Approval For All Indications In Wounds For Saudi Arabia

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)